Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Neuroendocrine cervical carcinoma (NECC) is a rare but highly aggressive tumor. The clinical management of NECC follows neuroendocrine neoplasms and cervical cancer in general. However, the diagnosis and prognosis of NECC remain dismal. The aim of this study was to identify a specific protein signature for the diagnosis of NECC.

Methods: Protein and gene expression data for NECC and other cervical cancers were retrieved or downloaded from self-collected samples or public resources. Eleven machine-learning algorithms were packaged into 66 combinations, of which we selected the optimal algorithm, including randomForest, SVM-RFE, and LASSO, to select key NECC specific dysregulated proteins (kNsDEPs). The diagnostic effect of kNsDEPs was validated by a set of predictive models and immunohistochemical staining method. The dysregulation patterns of kNsDEPs were further investigated in other neuroendocrine carcinomas.

Results: Our results showed that NECC displays distinctive biological characteristics, such as HPV18 infection, and exhibits unique molecular features, particularly an enrichment in cytoskeleton-related functions. Furthermore, secretagogin (SCGN), adenylyl cyclase-associated protein 2 (CAP2), and calcyclin-binding protein (CACYBP) were identified as kNsDEPs. These kNsDEPs play a central role in cytoskeleton protein binding and showcase robust diagnostic ability and specificity for NECC. Moreover, the concurrent upregulation of SCGN and CACYBP, along with the downregulation of CAP2, represents a unique feature of NECC, distinguishing it from other neuroendocrine carcinomas.

Conclusions: This study uncovers the significance of kNsDEPs and elucidates their regulated networks in the context of NECC. It highlights the pivotal role of kNsDEPs in NECC diagnosis, thus offering promising prospects for the development of diagnostic biomarkers for NECC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11720509PMC
http://dx.doi.org/10.1186/s12885-025-13454-zDOI Listing

Publication Analysis

Top Keywords

necc
11
specific protein
8
protein signature
8
neuroendocrine cervical
8
cervical carcinoma
8
knsdeps
7
protein
6
neuroendocrine
5
integrative machine
4
machine learning
4

Similar Publications

Background: Neuroendocrine cervical carcinoma (NECC) is a rare and highly aggressive gynecological tumor, with poor prognosis and limited standardized treatment options. Inflammation plays a significant role in tumor progression, and systemic inflammatory markers such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) have shown prognostic value in other malignancies. However, their role in NECC remains unclear.

View Article and Find Full Text PDF

Exceptional response to trastuzumab deruxtecan in recurrent neuroendocrine cervical cancer: A case report.

Gynecol Oncol Rep

August 2025

Stanford University, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology. 900 Blake Wilbur, Palo Alto, CA 94034, United States.

Objective: Neuroendocrine cervical carcinomas (NECC) are a rare and aggressive cervical cancer subtype that account for 1-1.5 % of all cervical cancers. Treatment options for recurrent NECC are limited and anticipated response rates are low.

View Article and Find Full Text PDF

Follow-up Imaging in Treated and Untreated Cerebral Aneurysms.

Neuroimaging Clin N Am

August 2025

Department of Neurosurgery, NYU Langone Health, New York, NY, USA; Department of Radiology, NYU Langone Health, New York, NY, USA.

Imaging follow-up is an established component of intracranial aneurysm management that allows ongoing assessment of rupture risk and timely intervention to maintain protection from bleeding. Yet the frequency, duration, and imaging modality for follow-up vary widely. This review outlines contemporary imaging techniques and practice for follow-up of treated and untreated aneurysms, highlighting existing knowledge gaps and technical limitations that limit standardization.

View Article and Find Full Text PDF

Clinical Management of Cerebral Aneurysms-: Endosaccular.

Neuroimaging Clin N Am

August 2025

Department of Neurosurgery, NYU Langone Health, New York, NY, USA; Department of Radiology, NYU Langone Health, New York, NY, USA; Department of Neurology, NYU Langone Health, New York, NY, USA.

Although the concept of treating cerebral aneurysms by filling the sac from the inside (endosaccular) started many years ago first with detachable balloons and then coils, the use of a single metallic resheathable device acting as a flow disruptor is a much more recent innovation. The most studied device among these is certainly the WEB, which became part of standard clinical practice for treatment of wide-neck bifurcation aneurysms. This study reviews the most important features of the WEB device with a short summary of the most important literature.

View Article and Find Full Text PDF

The Role of AI-driven Volumetric Aneurysm Analysis in the Management of Cerebral Aneurysms.

Neuroimaging Clin N Am

August 2025

Department of Neurological Surgery, Goodman Campbell Brain and Spine, Carmel.

This article looks at the current state of aneurysm risk modeling, exploring the limitations of linear measurement. It reviews articles using Food and Drug Administration (FDA)-approved artificial intelligence-driven volumetric measurement tools both for evaluating potential aneurysm growth in patients being managed conservatively as well as in assessing morphologic change prerupture and postrupture. The challenges of defining the aneurysm boundary are explored, and a novel definition of aneurysm/parent artery interface is proposed.

View Article and Find Full Text PDF